Population Health Management · 2023 · 19 citations · 35 references
MedicineHealth InformaticsCancer ScreeningHealth CommunicationPatient SafetyCancer CommunicationCare NavigationHealth Care NavigationPatient NavigationPopulation ScreeningScreeningBarriers To Screening UptakeCancer Screening OutreachHealth System ImplementationLung Cancer ScreeningMultinomial RegressionPatient Navigation WorkflowsPatient-provider Communication BarriersScreening Navigation
Low-dose computed tomography-based lung cancer screening represents a complex clinical undertaking that could require multiple referrals, appointments, and time-intensive procedures. These steps may pose difficulties and raise concerns among patients, particularly minority, under-, and uninsured populations. The authors implemented patient navigation to identify and address these challenges. They conducted a pragmatic randomized controlled trial of telephone-based navigation for lung cancer screening in an integrated, urban safety-net health care system. Following standardized protocols, bilingual (Spanish and English) navigators educated, motivated, and empowered patients to traverse the health system. Navigators made systematic contact with patients, recording standardized call characteristics in a study-specific database. Call type, duration, and content were recorded. Univariable and multivariable multinomial logistic regression was performed to investigate associations between call characteristics and reported barriers. Among 225 patients (mean age 63 years, 46% female, 70% racial/ethnic minority) assigned navigation, a total of 559 barriers to screening were identified during 806 telephone calls. The most common barrier categories were personal (46%), provider (30%), and practical (17%). System (6%) and psychosocial (1%) barriers were described by English-speaking patients, but not by Spanish-speaking patients. Over the course of the lung cancer screening process, provider-related barriers decreased 80% ( P = 0.008). The authors conclude that patients undergoing lung cancer screening frequently report personal and health care provider-related barriers to successful participation. Barrier types may differ among patient populations and over the course of the screening process. Further understanding of these concerns may increase screening uptake and adherence. Clinical Trial Registration number: (NCT02758054).
35
Alex H. Krist, Karina W. Davidson, Carol M. Mangione et al. · JAMA · 2021 · 1.7K citations · Full text
The National Lung Screening Trial: Overview and Study Design
Radiology · 2010 · 1.3K citations
Racial Differences in the Treatment of Early-Stage Lung Cancer
Peter B. Bach, Laura D. Cramer, Joan L. Warren et al. · New England Journal of Medicine · 1999 · 1K citations · Full text